Related Experiment Video

Updated: May 28, 2026

A Deep-sequencing-assisted, Spontaneous Suppressor Screen in the Fission Yeast Schizosaccharomyces pombe
07:55

A Deep-sequencing-assisted, Spontaneous Suppressor Screen in the Fission Yeast Schizosaccharomyces pombe

Published on: March 7, 2019

Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases

Kim M Keeling1, David M Bedwell

  • 1Department of Microbiology, Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL, USA.

Wiley Interdisciplinary Reviews. RNA
|October 7, 2011
PubMed

Insights

Suppression therapy uses drugs to read past premature stop signals in genetic diseases, enabling the production of functional proteins. Research focuses on improving drug efficacy and overcoming cellular mechanisms that limit this treatment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Background:

  • Genetic diseases are often caused by nonsense mutations leading to premature termination codons (PTCs).
  • Suppression therapy aims to restore the production of functional proteins by overcoming PTCs.

Purpose of the Study:

  • To review current suppression therapy strategies for genetic diseases caused by nonsense mutations.
  • To discuss methods for enhancing the efficiency of suppression therapy, including drug improvement and discovery.
  • To explore the role of nonsense-mediated mRNA decay (NMD) in limiting suppression therapy and strategies to modulate it.

Main Methods:

  • Review of existing literature on suppression therapy agents and their efficacy in mammalian cells.
  • Analysis of approaches to enhance current suppression drugs and discover novel agents.
  • Discussion of nonsense-mediated mRNA decay (NMD) mechanisms and their impact on therapy effectiveness.

Main Results:

  • Various classes of compounds show potential for suppressing PTCs in mammalian cells, but limitations exist.
  • Strategies for improving suppression efficiency include enhancing existing drugs and developing new ones.
  • Nonsense-mediated mRNA decay (NMD) significantly impacts suppression therapy efficacy, suggesting modulation as a therapeutic avenue.

Conclusions:

  • Suppression therapy holds promise for treating genetic diseases caused by nonsense mutations.
  • Enhancing drug effectiveness and modulating NMD are key strategies for advancing suppression therapy.
  • Further research into novel suppression agents and NMD regulation is crucial for clinical translation.

More Related Videos

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Concept Videos

Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...